BR9910415A - Novos compostos, uso de compostos, e, processo de regular a meiose - Google Patents

Novos compostos, uso de compostos, e, processo de regular a meiose

Info

Publication number
BR9910415A
BR9910415A BR9910415-6A BR9910415A BR9910415A BR 9910415 A BR9910415 A BR 9910415A BR 9910415 A BR9910415 A BR 9910415A BR 9910415 A BR9910415 A BR 9910415A
Authority
BR
Brazil
Prior art keywords
compounds
new
regulating
meiosis
regulating meiosis
Prior art date
Application number
BR9910415-6A
Other languages
English (en)
Inventor
Peter Faarup
Frederik Christian Gr Nvald
Thorsten Blume
Anthony Murray
Jens Breinholt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27220846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9910415(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP98250166A external-priority patent/EP0957108A1/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9910415A publication Critical patent/BR9910415A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • General Induction Heating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"NOVOS COMPOSTOS, USO DE COMPOSTOS, E, PROCESSO DE REGULAR A MEIOSE". Certos novos derivados de esterol podem ser usados para regular a meiose em ovócitos e em células germinativas masculinas.
BR9910415-6A 1998-05-13 1999-05-11 Novos compostos, uso de compostos, e, processo de regular a meiose BR9910415A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK65798 1998-05-13
EP98250166A EP0957108A1 (en) 1998-05-14 1998-05-14 Unsaturated cholestane derivatives, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
US8630698P 1998-05-21 1998-05-21
DK81198 1998-06-19
US9298398P 1998-07-16 1998-07-16
PCT/DK1999/000263 WO1999058549A1 (en) 1998-05-13 1999-05-11 Meiosis regulating compounds

Publications (1)

Publication Number Publication Date
BR9910415A true BR9910415A (pt) 2001-01-09

Family

ID=27220846

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910415-6A BR9910415A (pt) 1998-05-13 1999-05-11 Novos compostos, uso de compostos, e, processo de regular a meiose

Country Status (12)

Country Link
EP (1) EP1077992B1 (pt)
JP (1) JP2003522728A (pt)
CN (1) CN1326461A (pt)
AT (1) ATE256144T1 (pt)
AU (1) AU3701199A (pt)
BR (1) BR9910415A (pt)
CA (1) CA2331962A1 (pt)
DE (1) DE69913513T2 (pt)
HU (1) HUP0101898A3 (pt)
NO (1) NO20005667L (pt)
PL (1) PL344155A1 (pt)
WO (1) WO1999058549A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200101157A1 (ru) * 1999-05-10 2002-06-27 Шеринг Акциенгезельшафт 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ
EP1245572A1 (en) * 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003055991A1 (en) * 2001-12-21 2003-07-10 Rigshospitalet Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
PT3461834T (pt) 2013-03-13 2021-09-10 Sage Therapeutics Inc Esteroides neuroativos
MX2016008459A (es) 2013-12-24 2016-10-14 Univ Virginia Commonwealth Usos de sulfatos de colesterol oxigenados (soc).
US9637514B1 (en) 2015-10-26 2017-05-02 MAX BioPharma, Inc. Oxysterols and hedgehog signaling
PT3494125T (pt) 2016-08-02 2022-07-07 Durect Corp Composições compreendendo 5-colesten-3, 25-diol, 3-sulfato (25hc3s), ou seu sal farmaceuticamente aceitável, e, pelo menos, um oligossacárido cíclico
CN112521438B (zh) * 2020-12-08 2021-11-23 苏利制药科技江阴有限公司 一种β-谷甾醇的合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018225A1 (en) * 1993-02-11 1994-08-18 The Du Pont Merck Pharmaceutical Company 15-oxasterols as hypocholesterolemics
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
EP0946584B1 (en) * 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds
DK0984980T3 (da) * 1997-05-16 2003-03-17 Akzo Nobel Nv 20-aralkyl-5alfa-pregnan-derivater
US6262282B1 (en) * 1997-06-04 2001-07-17 Akzo Nobel N.V. 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis

Also Published As

Publication number Publication date
HUP0101898A2 (hu) 2002-04-29
JP2003522728A (ja) 2003-07-29
EP1077992B1 (en) 2003-12-10
PL344155A1 (en) 2001-10-08
EP1077992A1 (en) 2001-02-28
HUP0101898A3 (en) 2002-06-28
ATE256144T1 (de) 2003-12-15
CN1326461A (zh) 2001-12-12
CA2331962A1 (en) 1999-11-18
WO1999058549A1 (en) 1999-11-18
NO20005667L (no) 2001-01-12
DE69913513T2 (de) 2004-09-30
NO20005667D0 (no) 2000-11-10
AU3701199A (en) 1999-11-29
DE69913513D1 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
BR9508074A (pt) Composto e processo de regulagem de meiose em uma célula- embrião de mamífero
BR9910415A (pt) Novos compostos, uso de compostos, e, processo de regular a meiose
BR9608968A (pt) Composto e processo para regular meiose em uma célula germinativa de mamífero
HUP9904616A2 (hu) Meiózist befolyásoló holesztánszármazékok
NZ324887A (en) Piperazine and piperidine compounds with analgesic effect
MX9504332A (es) Derivados de amino(tio)eter y procedimiento para su preparacion.
BR9509269A (pt) Processo para tratar diabetes
AU6851696A (en) Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
BR9810554A (pt) Aroil piperazinas para regular a atividade sexual
NO20013862L (no) Fremgangsmåte for å regulere liposomstörrelse
BR9909468A (pt) Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral
BR9713709A (pt) Processo para hidratar de modo compatìvel um sólido fragmentado que forma um gel com composição aquosa.
DE69431162D1 (en) Fenbendazolformulierungen
TR199801665T2 (xx) Makular �demin engellenmesi i�in karbonik anhidraz inhibit�rlerinin kullan�m�.
AU1031697A (en) Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
BR9911340A (pt) Compostos, uso de compostos, e, processo de regulação de meiose.
CA2151123A1 (fr) Cellules modifiees au niveau du catabolisme de la betaine, preparation et utilisations, notamment pour la production de metabolites ou d'enzymes
MX9801133A (es) Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion.
BR9713762A (pt) Composto, uso dos mesmos, e, processo para regular a meiose em uma célula germinativa de mamìfero.
BR0005121A (pt) Sais complexos para uso em células eletroquìmicas
AU6105094A (en) Adjustable pilch
ES2165533T3 (es) Composicion para la proteccion de celulas vegetales.
BR9814497A (pt) Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular
MX9706565A (es) Estimulacion de meiosis.
MX9804797A (es) Nuevos compuestos con efecto analgesico.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements